Nifuratel
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561413

CAS#: 4936-47-4

Description: Nifuratel is a local antiprotozoal and antifungal agent that may also be given orally. Nifuratel is a drug used in gynecology.


Chemical Structure

img
Nifuratel
CAS# 4936-47-4

Theoretical Analysis

MedKoo Cat#: 561413
Name: Nifuratel
CAS#: 4936-47-4
Chemical Formula: C10H11N3O5S
Exact Mass: 285.04
Molecular Weight: 285.274
Elemental Analysis: C, 42.10; H, 3.89; N, 14.73; O, 28.04; S, 11.24

Price and Availability

Size Price Availability Quantity
200mg USD 250 2 Weeks
500mg USD 450 2 Weeks
1g USD 750 2 Weeks
5g USD 1650 2 Weeks
20g USD 2950 2 Weeks
Bulk inquiry

Synonym: Nifuratel; Macmiror; Magmilor; Nifuratelum; Omnes; Polmiror; Tydantil;

IUPAC/Chemical Name: 5-(Methylsulfanylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one

InChi Key: SRQKTCXJCCHINN-NYYWCZLTSA-N

InChi Code: InChI=1S/C10H11N3O5S/c1-19-6-8-5-12(10(14)18-8)11-4-7-2-3-9(17-7)13(15)16/h2-4,8H,5-6H2,1H3/b11-4+

SMILES Code: O=C1OC(CSC)CN1/N=C/C2=CC=C([N+]([O-])=O)O2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: Nifuratel(NF 113, SAP 113) is a broad antibacterial spectrum agent, which is used as an antibacterial, antifungal, and antiprotozoal (Trichomonas).
In vitro activity: This study reports that nifuratel, an antiprotozoal and antifungal drug, is a potent inhibitor of STAT3. This study found that nifuratel significantly suppressed proliferation and induced apoptosis of gastric cancer cells. Studies of the mechanism of action of nifuratel indicated that it acts by inhibiting the constitutive and interleukin-6-induced STAT3 activation. Reference: Cancer Manag Res. 2017 Nov 1;9:565-572. https://pubmed.ncbi.nlm.nih.gov/29138596/
In vivo activity: From the total of 1769 compounds, 12 hits with selective indices >35 were identified, and 4 of them were tested in vivo in a model of L. donovani visceral leishmaniasis. Nifuratel, a repurposed synthetic nitrofuran, when administered orally at 50 mg/kg bw once or twice a day for 10 days, caused >80% reduction in the parasitic load. Furthermore, the intralesional administration of nifuratel in a model of cutaneous leishmaniasis by L. major produced the parasitological cure. Reference: ACS Infect Dis. 2021 Aug 13;7(8):2390-2401. https://pubmed.ncbi.nlm.nih.gov/34114790/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 53.5 187.54

Preparing Stock Solutions

The following data is based on the product molecular weight 285.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Zheng H, Hong H, Zhang L, Cai X, Hu M, Cai Y, Zhou B, Lin J, Zhao C, Hu W. Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells. Cancer Manag Res. 2017 Nov 1;9:565-572. doi: 10.2147/CMAR.S146173. PMID: 29138596; PMCID: PMC5677376. 2. Domínguez-Asenjo B, Gutiérrez-Corbo C, Álvarez-Bardón M, Pérez-Pertejo Y, Balaña-Fouce R, Reguera RM. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. ACS Infect Dis. 2021 Aug 13;7(8):2390-2401. doi: 10.1021/acsinfecdis.1c00139. Epub 2021 Jun 11. PMID: 34114790.
In vitro protocol: 1. Zheng H, Hong H, Zhang L, Cai X, Hu M, Cai Y, Zhou B, Lin J, Zhao C, Hu W. Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells. Cancer Manag Res. 2017 Nov 1;9:565-572. doi: 10.2147/CMAR.S146173. PMID: 29138596; PMCID: PMC5677376.
In vivo protocol: 1. Domínguez-Asenjo B, Gutiérrez-Corbo C, Álvarez-Bardón M, Pérez-Pertejo Y, Balaña-Fouce R, Reguera RM. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. ACS Infect Dis. 2021 Aug 13;7(8):2390-2401. doi: 10.1021/acsinfecdis.1c00139. Epub 2021 Jun 11. PMID: 34114790.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Polatti F. Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol. 2012 Feb 1;7(1):36-40. Review. PubMed PMID: 22082330; PubMed Central PMCID: PMC3362959.

2: Gordeeva LM. [Chemotherapy of lambliasis (literature survey)]. Med Parazitol (Mosk). 1976 Sep-Oct;45(5):593-602. Review. Russian. PubMed PMID: 799750.